Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Obesity

fluorobenzenes has been researched along with Obesity in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.00)18.2507
2000's9 (45.00)29.6817
2010's10 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brudi, P; Hanson, ME; Jimenez, JG; Massaad, R; Pirags, V; Rosen, JB; Triscari, J; Vides, H1
Black, CA; Fleming, JW; Malinowski, SS; Miller, KH; Riche, DM; Wofford, MR1
Berger, H; Englert, H; Grittner, U; Katus, HA; Muckelbauer, R; Müller-Nordhorn, J; Prugger, C; Sonntag, F; Völler, H; Wegscheider, K; Willich, SN1
Busija, DW; Domoki, F; Gáspár, T; Katakam, PV; Mayanagi, K1
Cathey, BL; Moukdar, F; Prasad, RY; Wilkinson, L; Wingard, CJ1
Ferdinand, KC1
Balfagón, G; Blanco-Rivero, J; Cachofeiro, V; de las Heras, N; Lahera, V; Martín-Fernández, B1
Agatston, A; Blaha, MJ; Blankstein, R; Blumenthal, RS; Budoff, MJ; Criqui, MH; Cushman, M; Lakoski, S; Nasir, K; O'Leary, DH; Rivera, JJ; Szklo, M1
Targher, G1
Ansari, JA; Bhandari, U; Haque, SE; Pillai, KK2
Gierman, LM; Huizinga, TW; Kleemann, R; Kloppenburg, M; Kooistra, T; Koudijs, A; Stojanovic-Susulic, V; Stoop, R; van der Ham, F; van Osch, GJ; Wielinga, PY; Zuurmond, AM1
SoRelle, R1
Busija, DW; Erdös, B; Katakam, P; Miller, AW; Snipes, JA; Tulbert, CD1
Balligand, JL; Davey, PC; De Keyzer, D; Desjardins, F; Geeraert, B; Herregods, MC; Holvoet, P; Mertens, A; Smith, G; Verreth, W1
Cooper, SA; DeMarco, VG; Hayden, MR; Lastra, G; Manrique, C; Nistala, R; Sowers, JR; Wei, Y; Westerly, B; Whaley-Connell, A; Wiedmeyer, C1
Coppey, LJ; Davidson, EP; Kleinschmidt, TL; Lund, DD; Oltman, CL; Yorek, MA1
Al-Shamma, H; Behan, D; Chalmers, D; Chen, W; Espitia, S; Grottick, AJ; Martin, M; Menzaghi, F; Morgan, M; Reyes-Saldana, H; Smith, B; Thomsen, WJ; Whelan, K; Yuskin, D1
Boulanger, M; Della-Zuana, O; Duhault, J; Espinal, J; Lacour, F; Ravel, D; Wierzbicki, M1
Beal, P; Boulanger, M; Boussard, MF; Della-Zuana, O; Duhault, J; Fournier, J; Guette, JP; Wierzbicki, M1

Trials

1 trial(s) available for fluorobenzenes and Obesity

ArticleYear
Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects.
    Lipids in health and disease, 2013, Jul-16, Volume: 12

    Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Azetidines; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ezetimibe; Female; Fluorobenzenes; Heptanoic Acids; Humans; Male; Middle Aged; Obesity; Peptide Fragments; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome; Young Adult

2013

Other Studies

19 other study(ies) available for fluorobenzenes and Obesity

ArticleYear
Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:1

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, Combination; Dyslipidemias; Fatty Liver; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thiazolidinediones

2014
Longitudinal association between body mass index and health-related quality of life.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Aged; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Longitudinal Studies; Male; Middle Aged; Obesity; Pyrimidines; Quality of Life; Risk Factors; Rosuvastatin Calcium; Sulfonamides

2014
Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2008, Volume: 28, Issue:12

    Topics: Animals; Blood Glucose; Blotting, Western; Cerebrovascular Circulation; Cholesterol; Disease Models, Animal; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Nitric Oxide Synthase; Obesity; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Time Factors

2008
Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.
    The journal of sexual medicine, 2009, Volume: 6 Suppl 3

    Topics: Animals; Anticholesteremic Agents; Blotting, Western; Diabetes Mellitus, Experimental; Electric Stimulation; Enzyme Inhibitors; Erectile Dysfunction; Fluorobenzenes; Impotence, Vasculogenic; Intracellular Signaling Peptides and Proteins; Male; Metabolic Syndrome; Nitric Oxide; Obesity; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Zucker; rho-Associated Kinases; Rosuvastatin Calcium; Sulfonamides

2009
Achieving treatment goals in low-risk, asymptomatic patients.
    The Journal of the American Osteopathic Association, 2010, Volume: 110, Issue:4 Suppl 4

    Topics: Albuminuria; Antihypertensive Agents; Biomarkers; Black or African American; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Female; Fluorobenzenes; Health Status Indicators; Humans; Hypolipidemic Agents; Metabolic Syndrome; Middle Aged; Obesity; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; United States

2010
Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats.
    British journal of pharmacology, 2011, Volume: 162, Issue:1

    Topics: Adenosine Triphosphate; Animals; Blotting, Western; Calcitonin Gene-Related Peptide; Electric Stimulation; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type I; Norepinephrine; Obesity; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides

2011
Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:6

    Topics: Adult; Aged; Atherosclerosis; Body Mass Index; C-Reactive Protein; Calcium; Cardiovascular Diseases; Carotid Arteries; Clinical Trials as Topic; Cross-Sectional Studies; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Obesity; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tunica Intima; Tunica Media; Waist Circumference

2011
High-sensitivity C-reactive protein, obesity, and subclinical atherosclerosis: implications of JUPITER from the MESA study.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:6

    Topics: Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Obesity; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2011
Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats.
    Toxicology mechanisms and methods, 2012, Volume: 22, Issue:1

    Topics: Administration, Oral; Animals; Anti-Obesity Agents; Antioxidants; Apolipoproteins B; Cholesterol, HDL; Disease Models, Animal; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Lipid Peroxides; Myocardium; Obesity; Orlistat; Oxidative Stress; Pyrimidines; Quinolines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Triglycerides

2012
Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice.
    Arthritis and rheumatism, 2012, Volume: 64, Issue:4

    Topics: Animals; Body Weight; C-Reactive Protein; Cytokines; Diet, High-Fat; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Inflammation; Insulin; Male; Mice; Mice, Transgenic; Obesity; Osteoarthritis; Pyrimidines; Rosiglitazone; Rosuvastatin Calcium; Sulfonamides; Thiazolidinediones

2012
Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats--a preliminary study.
    Indian journal of experimental biology, 2012, Volume: 50, Issue:3

    Topics: Animals; Antioxidants; Diet, High-Fat; Female; Fluorobenzenes; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardium; Obesity; Oxidative Stress; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides

2012
Diagnosing familial combined hyperlipidemia.
    Circulation, 2004, Jun-22, Volume: 109, Issue:24

    Topics: Apolipoproteins B; Cardiology; Contraindications; Drug Labeling; Drug Resistance; European Union; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Insulin Resistance; Lipectomy; Obesity; Pyrimidines; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration

2004
Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:3

    Topics: Animals; Cerebral Arteries; Cerebrovascular Circulation; Diabetes Mellitus; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Male; NADPH Oxidases; Obesity; Pyrimidines; Rats; Rats, Zucker; Rosuvastatin Calcium; Sulfonamides; Superoxides; Treatment Outcome

2006
Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
    British journal of pharmacology, 2007, Volume: 151, Issue:3

    Topics: Animals; Aorta; Atherosclerosis; Blood Glucose; Body Weight; Cell Line; Dyslipidemias; Fluorobenzenes; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Leptin; Lipids; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; PPAR gamma; Pyrimidines; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Superoxide Dismutase

2007
Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
    American journal of nephrology, 2008, Volume: 28, Issue:1

    Topics: Albuminuria; Animals; Blood Glucose; Body Weight; Fluorobenzenes; Glomerular Filtration Rate; Homeostasis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Microscopy, Electron, Transmission; Obesity; Oxidative Stress; Podocytes; Pyrimidines; Rats; Rats, Zucker; Rosuvastatin Calcium; Sulfonamides; Superoxide Dismutase

2008
Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.
    Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:1

    Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Cardiovascular System; Disease Models, Animal; Enalapril; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Motor Neurons; Neural Conduction; Neurons, Afferent; Nociceptors; Obesity; Peripheral Nerves; Pyrimidines; Rats; Rats, Zucker; Rosuvastatin Calcium; Sciatic Nerve; Sulfonamides; Superoxides; Tyrosine; Vasodilator Agents

2008
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:2

    Topics: Aminopyridines; Animals; Behavior, Animal; Benzazepines; Body Weight; Brain; Cell Line; Dopamine; Eating; Fluorobenzenes; Humans; Indoles; Male; Norepinephrine; Obesity; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection

2008
S15261, a new compound for the treatment of the insulin resistance syndrome.
    Diabetologia, 1994, Volume: 37, Issue:10

    Topics: Animals; Blood Glucose; Blood Pressure; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorenes; Fluorobenzenes; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; In Vitro Techniques; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Liver Glycogen; Male; Obesity; Portal Vein; Rats; Rats, Sprague-Dawley; Syndrome; Triglycerides

1994
Preparation and pharmacological profile of 2-trifluoromethyl-benzo(8,9)-1,3-diaza-spiro (4,6)-undeca-2,8-diene and its enantiomers as new anti-obesity agents.
    Arzneimittel-Forschung, 2000, Volume: 50, Issue:12

    Topics: Animals; Anti-Obesity Agents; Appetite Depressants; Biogenic Monoamines; Blood Pressure; Brain Chemistry; Eating; Fluorobenzenes; In Vitro Techniques; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rats, Zucker; Receptors, Drug; Spiro Compounds; Stereoisomerism

2000